David K Wallace
Overview
Explore the profile of David K Wallace including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
3227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kehler L, Wallace D
JAMA Ophthalmol
. 2025 Jan;
143(2):163-164.
PMID: 39820954
No abstract available.
2.
Wang W, Freedman S, Wallace D, Prakalapakorn S
J AAPOS
. 2025 Jan;
29(1):104101.
PMID: 39746533
Plus disease was first defined in the original International Classification of retinopathy of prematurity (ICROP) publication in 1984. Over time, the definition of plus disease has evolved, and each ensuing...
3.
Wu R, Manny R, Holmes J, Melia B, Li Z, Wallace D, et al.
Invest Ophthalmol Vis Sci
. 2025 Jan;
66(1):4.
PMID: 39745678
Purpose: When treating amblyopia, it is important to define when visual acuity (VA) is no longer improving (i.e., stable) because treatment decisions may be altered based on this determination. Methods:...
4.
Miller A, Holmes J, Wu R, Kraker R, Crouch E, Lee K, et al.
J AAPOS
. 2024 Apr;
28(3):103905.
PMID: 38574967
We evaluated whether doses of bilateral medial rectus recessions greater than Parks's tables yielded superior outcomes for adult-onset divergence insufficiency. Forty-two patients underwent bilateral medial rectus recessions. Dose was analyzed...
5.
6.
Freedman S, Wallace D
Ophthalmology
. 2023 Jan;
130(5):e18-e19.
PMID: 36702727
No abstract available.
7.
Wallace D, Hercinovic A, Freedman S, Crouch E, Bhatt A, Hartnett M, et al.
J AAPOS
. 2023 Jan;
27(1):10.e1-10.e8.
PMID: 36681111
Purpose: To report 2-year ocular and developmental outcomes for infants receiving low doses of intravitreal bevacizumab for type 1 retinopathy of prematurity (ROP). Methods: A total of 120 premature infants...
8.
Hutchinson A, Morse C, Hercinovic A, Cruz O, Sprunger D, Repka M, et al.
Ophthalmology
. 2022 Dec;
130(3):P222-P270.
PMID: 36543602
No abstract available.
9.
Sprunger D, Lambert S, Hercinovic A, Morse C, Repka M, Hutchinson A, et al.
Ophthalmology
. 2022 Dec;
130(3):P179-P221.
PMID: 36526451
No abstract available.
10.
Cruz O, Repka M, Hercinovic A, Cotter S, Lambert S, Hutchinson A, et al.
Ophthalmology
. 2022 Dec;
130(3):P136-P178.
PMID: 36526450
No abstract available.